Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis

International Journal of Cardiology

Volumn 199, Issue , 2015, Pages 204-212

  Wu, Ben J ^a,b,c   Shrestha, Sudichhya ^a,b   Ong, Kwok L ^a,b,c   Johns, Douglas ^d   Dunn, Louise L ^b,e   Hou, Liming ^a,b   Barter, Philip J ^a,b,c   Rye, Kerry Anne ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MERCK RESEARCH LABORATORIES   (United States)

^e VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

Author keywords

Angiogenesis; CETP inhibition; High density lipoproteins; Ischemia; Lipoproteins

Indexed keywords

ANACETRAPIB; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PDZ PROTEIN; PDZK1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; ANGIOGENIC FACTOR; APOA1 PROTEIN, HUMAN; HYPOCHOLESTEROLEMIC AGENT; OXAZOLIDINONE DERIVATIVE;

ADDUCTOR MUSCLE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY ENDOTHELIUM; ARTERY LIGATION; ARTICLE; CAPILLARY DENSITY; CELL LEVEL; CHOLESTEROL BLOOD LEVEL; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME INHIBITION; FEMORAL ARTERY; GENE SILENCING; HINDLIMB; HUMAN; HUMAN CELL; LIMB ISCHEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SKELETAL MUSCLE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; ISCHEMIA; METABOLISM; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; RABBIT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; ENDOTHELIAL CELLS; HINDLIMB; HUMANS; ISCHEMIA; LIPOPROTEINS, HDL; OXAZOLIDINONES; PERIPHERAL VASCULAR DISEASES; PHOSPHATIDYLINOSITOL 3-KINASES; RABBITS;

EID: 84941571152     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.014     Document Type: Article

References (28)

1. L. Calabresi, G. Rossoni, M. Gomaraschi, F. Sisto, F. Berti, and G. Franceschini High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release Circ. Res. 92 2003 330 337
2. M.A. Frias, S. Pedretti, D. Hacking, S. Somers, L. Lacerda, L.H. Opie, R.W. James, and S. Lecour HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity Atherosclerosis 228 2013 110 116
3. G. Theilmeier, C. Schmidt, J. Herrmann, P. Keul, M. Schäfers, I. Herrgott, J. Mersmann, J. Larmann, S. Hermann, J. Stypmann, O. Schober, R. Hildebrand, R. Schulz, G. Heusch, M. Haude, Lipinski K. von Wnuck, C. Herzog, M. Schmitz, R. Erbel, J. Chun, and B. Levkau High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor Circulation 144 2006 1403 1409
4. R. Tao, H.E. Hoover, N. Honbo, M. Kalinowski, C.C. Alano, J.S. Karliner, and R. Raffai High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate Am. J. Physiol. Heart Circ. Physiol. 298 2010 H1022 H1028
5. M. Sumi, M. Sata, S. Miura, K.A. Rye, N. Toya, Y. Kanaoka, K. Yanaga, T. Ohki, K. Saku, and R. Nagai Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis Arterioscler. Thromb. Vasc. Biol. 27 2007 813 818
6. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, and B. Brewer Effects of torcetrapib in patients at high risk for coronary events N. Engl. J. Med. 357 2007 2109 2122
7. G.G. Schwartz, A.G. Olsson, M. Abt, C.M. Ballantyne, P.J. Barter, J. Brumm, B.R. Chaitman, I.M. Holme, D. Kallend, L.A. Leiter, E. Leitersdorf, J.J. McMurray, H. Mundl, S.J. Nicholls, P.K. Shah, J.C. Tardif, R.S. Wright, and dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome N. Engl. J. Med. 367 2012 2089 2099
8. C.P. Cannon, S. Shah, H.M. Dansky, M. Davidson, E.A. Brinton, A.M. Gotto, M. Stepanavage, S.X. Liu, P. Gibbons, T.B. Ashraf, J. Zafarino, Y. Mitchel, and P. Barter Determining the efficacy and tolerability investigators. Safety of anacetrapib in patients with or at high risk for coronary heart disease N. Engl. J. Med. 363 2010 2406 2415
9. S.J. Nicholls, H.B. Brewer, J.J. Kastelein, K.A. Krueger, M.D. Wang, M. Shao, B. Hu, E. McErlean, and S.E. Nissen Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial JAMA 306 2011 2099 2109
10. W.D. Ito, M. Arras, D. Scholz, B. Winkler, P. Htun, and W. Schaper Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion Am. J. Physiol. 273 1997 H1255 H1265
11. J.H. Tollefson, A. Liu, and J.J. Albers Regulation of plasma lipid transfer by the high-density lipoproteins Am. J. Physiol. 255 1988 E894 E902
12. M.A. Clay, D.H. Pyle, K.A. Rye, and P.J. Barter Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase J. Biol. Chem. 275 2000 9019 9025
13. F. Stähler, W. Gruber, K. Stinshoff, and P. Röschlau A practical enzymatic cholesterol determination Med. Lab. (Stuttg) 30 1977 29 37
14. J.K. Allen, W.J. Hensley, A.V. Nicholls, and J.B. Whitfield An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol Clin. Chem. 25 1979 325 327
15. B.J. Wu, S. Shrestha, K.L. Ong, D. Johns, L. Hou, P.J. Barter, and K.A. Rye Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit Arterioscler. Thromb. Vasc. Biol. 35 2015 628 636
16. S. Saddar, C. Mineo, and P.W. Shaul Signaling by the high-affinity HDL receptor scavenger receptor B type I Arterioscler. Thromb. Vasc. Biol. 30 2010 144 150
17. E.C. Turner, E.P. Mulvaney, H.M. Reid, and B.T. Kinsella Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis Mol. Biol. Cell 22 2011 2664 2679
18. P.J. Sabia, E.R. Powers, M. Ragosta, I.J. Sarembock, L.R. Burwell, and S. Kaul An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction N. Engl. J. Med. 327 1992 1825 1831
19. C. Seiler, M. Stoller, B. Pitt, and P. Meier The human coronary collateral circulation: development and clinical importance Eur. Heart J. 34 2013 2674 2682
20. J.T. Tan, H.C. Prosser, L.Z. Vanags, S.A. Monger, M.K. Ng, and Bursil lCA High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α FASEB J. 28 2014 206 217
21. H.C. Prosser, J.T. Tan, L.L. Dunn, S. Patel, L.Z. Vanags, S. Bao, M.K. Ng, and C.A. Bursill Multifunctional regulation of angiogenesis by high-density lipoproteins Cardiovasc. Res. 101 2014 145 154
22. D.J. Gordon, and B.M. Rifkind High-density lipoprotein - the clinical implications of recent studies N. Engl. J. Med. 321 1989 1311 1316
23. P.P. Toth Pharmacomodulation of high-density lipoprotein metabolism as a therapeutic intervention for atherosclerotic disease Curr. Cardiol. Rep. 12 2010 481 487
24. M. Sata, and R. Nagai Phosphatidylinositol 3-kinase: a key regulator of vascular tone? Circ. Res. 91 2002 273 275
25. C. Tso, G. Martinic, W.H. Fan, C. Rogers, K.A. Rye, and P.J. Barter High-density lipoproteins enhance progenitor-mediated endothelium repair in mice Arterioscler. Thromb. Vasc. Biol. 26 2006 1144 1149
26. T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver, M. Kearne, M. Magner, and J.M. Isner Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ. Res. 85 1999 221 228
27. M. Sata Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models Arterioscler. Thromb. Vasc. Biol. 26 2006 1008 1014
28. D. Ribatti, and S. Baiguera Phase II angiogenesis stimulators Expert Opin. Investig. Drugs 22 2013 1157 1166